These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
363 related items for PubMed ID: 21288251
1. Regulatory environment for allergen-specific immunotherapy. Kaul S, May S, Lüttkopf D, Vieths S. Allergy; 2011 Jun; 66(6):753-64. PubMed ID: 21288251 [Abstract] [Full Text] [Related]
8. [Registration of new medicinal products in Europe]. Singer E. Onkologie; 2008 Jun; 31 Suppl 2():64-6. PubMed ID: 18487872 [Abstract] [Full Text] [Related]
9. Granting marketing authorisation for medicines in South East European countries: the point of view of the authority. Tomić S, Sucić AF, Martinac AI. Regul Toxicol Pharmacol; 2010 Jun; 57(2-3):325-32. PubMed ID: 20385190 [Abstract] [Full Text] [Related]
18. European Union guidance on the quality, safety and efficacy of DNA vaccines and regulatory requirements. Robertson JS, Cichutek K. Dev Biol (Basel); 2000 Dec; 104():53-6. PubMed ID: 11713824 [Abstract] [Full Text] [Related]
19. Comparison of allergen immunotherapy practice patterns in the United States and Europe. Cox L, Jacobsen L. Ann Allergy Asthma Immunol; 2009 Dec; 103(6):451-59; quiz 459-61, 495. PubMed ID: 20084837 [Abstract] [Full Text] [Related]
20. Understanding differences in allergen immunotherapy products and practices in North America and Europe. Mahler V, Esch RE, Kleine-Tebbe J, Lavery WJ, Plunkett G, Vieths S, Bernstein DI. J Allergy Clin Immunol; 2019 Mar; 143(3):813-828. PubMed ID: 30850069 [Abstract] [Full Text] [Related] Page: [Next] [New Search]